Burns J W & Co. Inc. NY Trims Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Burns J W & Co. Inc. NY reduced its stake in UnitedHealth Group by 86.5% in the second quarter, now holding only 1,755 shares valued at approximately $548,000.
• UnitedHealth Group reported earnings per share (EPS) of $4.08 for the last quarter, missing expectations of $4.45, while revenue also came in slightly below forecasts.
• The company will pay a quarterly dividend of $2.21 per share on September 23rd, yielding an annualized dividend of 2.6%.

Burns J W & Co. Inc. NY trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 86.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,755 shares of the healthcare conglomerate's stock after selling 11,199 shares during the period. Burns J W & Co. Inc. NY's holdings in UnitedHealth Group were worth $548,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Two Sigma Advisers LP bought a new position in UnitedHealth Group in the fourth quarter worth about $14,063,000. First Heartland Consultants Inc. increased its stake in shares of UnitedHealth Group by 6.3% during the fourth quarter. First Heartland Consultants Inc. now owns 1,240 shares of the healthcare conglomerate's stock valued at $627,000 after purchasing an additional 74 shares in the last quarter. Finally, Novem Group bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $854,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 2.0%

Shares of UNH stock opened at $334.74 on Friday. The stock has a market cap of $303.16 billion, a P/E ratio of 14.50, a PEG ratio of 2.23 and a beta of 0.45. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company's fifty day simple moving average is $295.01 and its two-hundred day simple moving average is $366.14.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Analyst Ratings Changes

Several equities research analysts have commented on UNH shares. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Bank of America boosted their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. Finally, KeyCorp cut their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.